Cancerous Tumors

Double whammy for triple negative breast cancer

A promising new combination therapy for a particularly aggressive form of breast cancer has been identified by Weizmann Institute scientists, as was recently reported in Cancer Research. The potential dual-acting therapeutic ...

23 hours ago
popularity0 comments 0

An unexpected role for epigenetic enzymes in cancer

To better understand how cancer initiates and spreads, Yale associate professor of pathology Qin Yan turned to the field of epigenetics, which examines changes in the expression of genes and proteins that do not affect the ...

3 hours ago
popularity0 comments 0

Study shows promising clinical activity

Immune cellular therapy is a promising new area of cancer treatment. Anti-cancer therapeutics, such as chimeric antigen receptor (CAR) modified T cells, can be engineered to target tumor-associated antigens to attack and ...

23 hours ago
popularity0 comments 0

In cancer immunotherapy, one PD-L1 test to rule them all?

Clinical trials have proven the power of immunotherapies targeting PD-L1 or PD-1 in a range of cancers. However, these same trials show that only some patients benefit - tumors must depend on PD-L1 to be affected when medicines ...

Dec 01, 2016
popularity3 comments 0

Researchers uncover protein-based 'cancer signature'

A research team at the University of Basel's Biozentrum has investigated the expression of ribosomal proteins in a wide range of human tissues including tumors and discovered a cancer type specific signature. As the researchers ...

Dec 05, 2016
popularity0 comments 0

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News